Fundraising Fox
iXpressGenes
Huntsville, US · Alabama corporation · 1 known investors
Find your way into iXpressGenes
Sign up to see every warm intro you have to iXpressGenes
- Paths you didn't know you had: your email and LinkedIn already hold routes to the iXpressGenes team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
iXpressGenes operates a CLIA-certified, CAP-accredited molecular diagnostics laboratory that provides genetic testing and analysis services.
Founders & leadership
Board
PS
Peggy SammonBoard director
BF
Barbara FiskBoard director
Investors · 1
Funding
SEC filings, press & company announcements$2.4M disclosed across 1 of 2 rounds · 2009–2025
- Undisclosed amountseed fundingJul 2025Source ↗
▶$2.4MraisedJun 2025 · 13 investors · BiotechnologyRule 506(b)
▶$2.4MraisedJun 2025 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peggy SammonDirector
- John SchmittExecutive Officer, Director
- Barbara FiskDirector
- Joseph NgExecutive Officer, Director
- Offering amount
- $4.2M
- Amount sold
- $2.4M
- First sale
- Sep 2009
- Incorporated
- Corporation, Alabama
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 9 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseOffice for Chemical and Biological Defense | Phase II | 2017 | $1000K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2016 | $958.3K |
| Department of DefenseOffice for Chemical and Biological Defense | Phase I | 2016 | $143.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2015 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2013 | $743.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2010 | $744.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2010 | $100K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $100K |
| National Science Foundation | Phase ISTTR | 2006 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does iXpressGenes do?
- iXpressGenes operates a CLIA-certified, CAP-accredited molecular diagnostics laboratory that provides genetic testing and analysis services.
- Who are iXpressGenes's investors?
- iXpressGenes's investors include gener8tor.
- How much funding has iXpressGenes raised?
- iXpressGenes has disclosed $2.4M raised across 1 of its 2 known rounds.
- Where is iXpressGenes headquartered?
- iXpressGenes is headquartered in Huntsville, US.